The forecasted sales of blood and blood-forming organs medicine in Canada indicate a steady growth from 2024 to 2028, with values increasing from $34.1 to $38.2 US dollars per capita. Year-on-year growth stands at approximately 3%, showcasing a consistent upward trend. Over the longer horizon from 2024 to 2028, the compound annual growth rate is anticipated to be around 2.9%, reflecting a stable increase in sales per capita.
Future trends to watch for include:
- Advancements in personalized medicine that may drive demand.
- Potential regulatory changes impacting pricing and availability.
- Increased focus on blood disorder research and new treatment approvals.
- Demographic shifts impacting supply and demand dynamics.
